The optimal preparation for stem cell transplantation (SCT) in children with congenital immunodeficiencies is currently unknown. In all, 81 children with immunodeficiency underwent 82 SCTs using reduced-intensity conditioning (RIC). The incidence of significant GVHD was low; viral reactivation was prominent with an unexpected increase in EBV reactivation; immune reconstitution was similar between different donor groups and comparable to conventional SCT. Overall, 68/81 (84%) survive with no significant difference between donor types or between severe combined immunodeficiency (SCID) and non-SCID diseases. Findings suggest a significant survival advantage in the unrelated donor setting for RIC compared to conventional SCT. Bone Marrow Transplantation (2005) 35, S45-S47.
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Reduced-intensity conditioning (RIC) is a logical choice for preparation of children with congenital immunodeficiencies undergoing hematopoietic stem cell transplantation (SCT). These diseases do not require supralethal chemoradiotherapy to eradicate malignancy, and stable mixed chimerism is sufficient to cure the genetic abnormality. Furthermore, many of these children have significant comorbidities at the time of SCT and are unable to tolerate intensive regimens. RIC may have a further advantage in reducing some of the long-term sequelae of conventional transplant in these young children. This report details the use of RIC SCT in a large cohort of children with congenital immunodeficiencies over a 5-year period.
Patients
In all, 81 children, median age 3.5 yrs (0.1-17.6 yrs), received 82 SCTs at Great Ormond Street Hospital 
Results
Acute GVHD was grade II or less, and cGVHD limited in most patients (Figures 1 and 2 ). Both aGVHD and cGVHD were increased in mMUDs. Viral reactivation was significant with an unexpected increase in EBV reactivation compared to conventional procedures (Figures 3 and 4) .
T-cell chimerism is shown in Figure 5 ; low-level donor chimerism was more common in mMUD and MFD/ MSDs. A comparison of BM vs PBPCs in the mMUD setting is shown in Figure 6 . The use of PBSCs gave better donor chimerism, at the cost of more GVHD; viral reactivation and survival were similar.
Immune reconstitution was similar between the different donor groups (Figure 7) and has previously been shown to be comparable to conventional SCT in the RIC MUD/ mMUD setting.
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In all, 68/81 (84%) survive with no significant difference between the donor types or between SCID and non-SCID diseases (Figures 8 and 9) . A previous study in congenital immunodeficiencies showed a significant survival advantage in the MUD/mMUD setting for RIC 31/33 (94%) compared to conventional SCT 10/19 (53%).

Conclusion
RIC CT is well tolerated by children with congenital immunodeficiencies even in the presence of organ dysfunction. In this group of patients, RIC may be the preparation of choice in the UD setting, where as well as improved survival RIC SCT may offer the potential for reduced late effects over conventional SCT. 
